CLINICAL TRIALS PROFILE FOR CARVEDILOL
✉ Email this page to a colleague
All Clinical Trials for CARVEDILOL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000294 ↗ | Effects of Carvedilol on Cocaine Use in Humans - 11 | Completed | University of Minnesota | Phase 2 | 1998-09-01 | The purpose of this study is to examine carvedilol effects in response to cocaine. |
| NCT00000294 ↗ | Effects of Carvedilol on Cocaine Use in Humans - 11 | Completed | University of Minnesota - Clinical and Translational Science Institute | Phase 2 | 1998-09-01 | The purpose of this study is to examine carvedilol effects in response to cocaine. |
| NCT00000294 ↗ | Effects of Carvedilol on Cocaine Use in Humans - 11 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | 1998-09-01 | The purpose of this study is to examine carvedilol effects in response to cocaine. |
| NCT00004854 ↗ | The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart Failure | Completed | National Center for Research Resources (NCRR) | Phase 1 | 1969-12-31 | We would like to see if using Carvedilol in adjunct with Ace inhibitors will increase ejection fraction of the heart under echo. All interpretation of data will be sent to Boston Children's Hospital to be reviewed, which is the primary research center in this study. There are 5 hospitals participating in this study. The population targeted are children with moderate heart failure and must be on Ace inhibitors at the time of enrollment. Our outcome after placing them on Carvedilol is to change their ejection fraction on echo. The patients will be seen every 1-2 weeks, while we will titrate their medication to a maintenance dose. Secondary outcome is to increase quality of life, exercise tolerance and decrease their symptom scores as noted on their questionnaires. |
| NCT00052026 ↗ | Safety and Efficacy Study of Carvedilol to Treat Children With Congestive Heart Failure | Completed | University of Utah | Phase 3 | 2000-05-01 | The purpose of this study is to determine whether a new medicine, called carvedilol, improves symptoms and heart function in children who have congestive heart failure (diminished function of their heart muscle that pumps blood to the body). To accomplish this, we will give carvedilol to some patients who have diminished heart function and congestive heart failure and see whether symptoms and heart function are better at the end of an 8 month period in those who received carvedilol compared to the other patients who did not receive carvedilol. We will be testing 2 different doses of carvedilol compared to no additional medicine. |
| NCT00052026 ↗ | Safety and Efficacy Study of Carvedilol to Treat Children With Congestive Heart Failure | Completed | Shaddy, Robert, M.D. | Phase 3 | 2000-05-01 | The purpose of this study is to determine whether a new medicine, called carvedilol, improves symptoms and heart function in children who have congestive heart failure (diminished function of their heart muscle that pumps blood to the body). To accomplish this, we will give carvedilol to some patients who have diminished heart function and congestive heart failure and see whether symptoms and heart function are better at the end of an 8 month period in those who received carvedilol compared to the other patients who did not receive carvedilol. We will be testing 2 different doses of carvedilol compared to no additional medicine. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CARVEDILOL
Condition Name
Clinical Trial Locations for CARVEDILOL
Trials by Country
Clinical Trial Progress for CARVEDILOL
Clinical Trial Phase
Clinical Trial Sponsors for CARVEDILOL
Sponsor Name
